knowledge -WSS

knowledge

author：Wikipedia 2025-09-14 10:09:31 - browse：6

ESMO signage in Madrid. — At ESMO 2023, antibody-drug conjugates were featured prominently. Andrew Joseph/STAT

MADRID — If you had to pinpoint one subject that stood out at this year’s European Society for Medical Oncology meeting, a massive conference with thousands of people from 140-some countries and 2,500 studies presented, it would be a burgeoning type of cancer treatment called antibody-drug conjugates.

The conference opened to the news that Merck had signed one of the biggest licensing deals in industry history — worth up to $22 billion — to partner on three of the compounds from ADC specialist Daiichi Sankyo. GSK followed up with an ADC licensing announcement of its own (if a much smaller one). Multiple ADC studies were presented at the meeting’s top sessions. ADCs were, in short, the belle of the cancer research ball.

The thing is, ADCs are actually quite an old approach.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Eli Lilly to pay $200M for Beam’s stake in gene

leisure time

Wikipedia

WSS

Readout Newsletter: What happened with Sarepta's Duchenne data

China dismisses criticism of top diplomat's comments appearing to push for race

Telehealth options flood the market as retailers push virtual care

Adele warns fans about throwing things at performers onstage

Senate panel to vote on hospitals, PBMs, prisoner care

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

entertainment

knowledge

knowledge

Alkermes shareholders re

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Hepatitis C has a cure — but many Americans still lack access to it

Hospitals warn Medicare's drug payment fix is ‘unlawful’

Drug repurposing or repositioning? The language matters

WHO may add ‘noma' to its list of neglected tropical diseases

Wildfire smoke exposes gaps in outdoor worker protections

Medtronic CEO on promising devices for diabetes, hypertension

Cancer drug shortages should be causing more outrage

Gov. Ron DeSantis' push for 'civics' education: What does it look like?

explore

Medtronic CEO on promising devices for diabetes, hypertension

Readout Newsletter: New research from Sanofi, Regeneron, etc.

Readout Newsletter: What happened with Sarepta's Duchenne data

Philadelphia mass shooting: Few answers in apparently random attack as suspect charged with murder

Pentagon will tighten controls on classified information after Discord leak

Readout Newsletter: What happened with Sarepta's Duchenne data

leisure time

Wikipedia

entertainment

hotspot